1. In Vivo

Exploring Alltrna’s Rare Disease Platform

 
• By Janelle Hart

Michelle Werner, CEO of Alltrna, sat down with In Vivo to discuss rare disease as an increasingly important area of study, innovation in the space and how the emerging biotech hopes to impact the treatment landscape.

rare disease concept
• Source: Shutterstock

Rising Leaders Home

After twenty years in the pharma sector, Michelle Werner re-entered biotech on a mission to bring Alltrna’s technology to market....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rising Leaders

More from Leadership